Skip to main content

Miquel Vila Bover

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

Institutions of which they are part

Head of group
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

Miquel Vila Bover

Institutions of which they are part

Head of group
Neurodegenerative Diseases
Vall Hebron Institut de Recerca

I am an ICREA Professor and I lead the Research Group on Neurodegenerative Diseases at the Vall d'Hebron Research Institute (VHIR)

I have a degree in Medicine and Surgery from the University of Barcelona (1993) and a PhD in Neuroscience from the University of Paris 6 (1998). My doctoral work carried out in the laboratory of experimental neurology at the Salpetriere Hospital in Paris (1993-98) contributed to establishing the subthalamic nucleus as the main therapeutic target for the surgical treatment of Parkinson's disease with deep brain stimulation. From 1998 to 2005 I worked at the Movement Disorders Unit of Columbia University in New York (USA), initially as a postdoctoral researcher and from 2001 as an Assistant Professor of Neurology, focusing on the study of the mechanisms of neuronal death in Parkinson's disease to identify new therapeutic targets for this currently incurable neurodegenerative disorder.

In 2006 I moved to Barcelona as a Professor at ICREA (Catalan Institute of Research and Advanced Studies) to create and lead a new research group in neurodegenerative diseases at the Vall d'Hebron Research Institute (VHIR). Our group is now part of the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED) and the Aligning Science Across Parkinson's Collaborative Research Network (ASAP-CRN).

I am also an Associate Professor at the Autonomous University of Barcelona, Principal Investigator at CIBERNED, Coordinating Lead PI at ASAP-CRN and member of the Steering Committees of the World Parkinson Coalition and the Basic Science Special Interest Group of the International Parkinson and Movement Disorder Society.

Projects

Generation of humanized mouse models to study the role of neuromelanin in Parkinson disease

IP: Miquel Vila Bover
Collaborators: -
Funding agency: Parkinson's UK
Funding: 48053.2
Reference: MOUSEMOD_PARKINSONUK2015
Duration: 01/01/2015 - 31/12/2015

Rol de la neuromelanina y alfa-sinucleína en el inicio y extensión de la Enfermedad de Parkinson: potencial diagnóstico y terapéutico en nuevos modelos pre-clínicos

IP: Miquel Vila Bover
Collaborators: Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 82400
Reference: FI14/00613
Duration: 01/01/2015 - 31/12/2018

Disfunción mitocondrial en la enfermedad de Parkinson: papel de la dinámica mitocondrial

IP: Miquel Vila Bover
Collaborators: Laia Perez Lasarte
Funding agency: Ministerio de Educación, Cultura y Deporte
Funding: 61544
Reference: FPU13/01339
Duration: 02/09/2014 - 31/01/2018

Prion-like Dissemination of Synuclein Pathology: A Non-human Study

IP: Miquel Vila Bover
Collaborators: -
Funding agency: Michael J. Fox Foundation
Funding: 374375
Reference: PRIONLIKE_MJFF2013
Duration: 01/01/2014 - 31/12/2016

Related news

The initiative seeks to raise awareness of the disease and promote the well-being of those affected, while fostering empathy and scientific vocations among young people.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Related professionals

Andrea Lorite Gonzalez

Andrea Lorite Gonzalez

Research technician
Cardiovascular Diseases
Read more
Pablo Marino Castro Garcia

Pablo Marino Castro Garcia

Research assistant
Biomedical Research in Melanoma
Read more
Ares Selles Rius

Ares Selles Rius

Research technician
Rheumatology
Read more
Tayná  Marques

Tayná Marques

Research technician
Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.